Phase 3 Randomized-Controlled Trials Evaluating Efficacy and Safety of Subcutaneous Efgartigimod PH20 Using Pre-Filled Syringes in Patients with Graves’ Disease Inadequately Controlled with Antithyroid Drugs: Trials in Progress

Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) - argenx

Kristien Boelaert; Chrysoula Dosiou; Tomasz Bednarczuk; Colin Dayan; Kris Vande Walle; Kelly Hogan; Ivaylo Stoykov; Miloš Žarković; Mario Salvi

Aug 10, 2026